Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hippo Holdings (HIPO) Cash & Equivalents (2020 - 2025)

Hippo Holdings' Cash & Equivalents history spans 6 years, with the latest figure at $218.3 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 10.48% year-over-year to $218.3 million; the TTM value through Dec 2025 reached $218.3 million, up 10.48%, while the annual FY2025 figure was $218.3 million, 10.48% up from the prior year.
  • Cash & Equivalents reached $218.3 million in Q4 2025 per HIPO's latest filing, down from $247.7 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $818.7 million in Q4 2021 to a low of $101045.0 in Q2 2021.
  • Average Cash & Equivalents over 5 years is $279.1 million, with a median of $234.6 million recorded in 2023.
  • The largest YoY upside for Cash & Equivalents was 321044.04% in 2022 against a maximum downside of 70.14% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $818.7 million in 2021, then plummeted by 70.14% to $244.5 million in 2022, then dropped by 20.2% to $195.1 million in 2023, then grew by 1.28% to $197.6 million in 2024, then increased by 10.48% to $218.3 million in 2025.
  • Per Business Quant, the three most recent readings for HIPO's Cash & Equivalents are $218.3 million (Q4 2025), $247.7 million (Q3 2025), and $198.9 million (Q2 2025).